Studies have shown that the upregulation of hsaMrs2p regulates Mg2+ concentration by downregulating p27 and upregulating cyclin D1, while also inhibiting the release of mitochondrial cytochrome C, thereby conferring multiple drug resistance to gastric cancer cells. The gene discussed is CCND1; the disease is gastric cancer.